Evaluation and management of platelet transfusion refractoriness
Human acute myeloid leukemia stem cells: evolution of concept
Advances in laboratory assessment of thrombosis and hemostasis
Blood Res 2022; 57(2): 101~94
Images of Hematology
Smudge cells in CD200+, TP53 mutated leukemic mantle cell lymphoma
Preetesh Jain, Xin Han, Michael Wang et al.
Blood Res 2022; 57(2): 85-85  https://doi.org/10.5045/br.2022.2020113 PDF
Review Articles
Korean clinical practice guidelines for the diagnosis of hereditary hemolytic anemia
Hee Won Chueh, Sang Mee Hwang, Ye Jee Shim et al.
Blood Res 2022; 57(2): 86-94  https://doi.org/10.5045/br.2022.2021224 PDF
Chronic myeloid leukemia: a type of MPN
Muhammad Ammar Samad, Eman Mahboob, Hussain Mansoor
Blood Res 2022; 57(2): 95-100  https://doi.org/10.5045/br.2022.2021173 PDF
Diabetes mellitus and diabetic nephropathy: a review of the literature on hemostatic changes in coagulation and thrombosis
Ashwag Saleh Alsharidah
Blood Res 2022; 57(2): 101-105  https://doi.org/10.5045/br.2022.2021204 PDF
Multidisciplinary supportive care in systemic light chain amyloidosis
Bou Zerdan Maroun, Sabine Allam, Chakra P. Chaulagain
Blood Res 2022; 57(2): 106-116  https://doi.org/10.5045/br.2022.2021227 PDF
Original Articles
Diffuse large B-cell lymphoma (DLBCL) is infiltrated with activated CD8+ T-cells despite immune checkpoint signaling
Adam M. Greenbaum, Jonathan R. Fromm, Ajay K. Gopal et al.
Blood Res 2022; 57(2): 117-128  https://doi.org/10.5045/br.2022.2021145 PDF
The impact of nucleic acid testing as a blood donor screening method in transfusion-associated hepatitis C among children with bleeding disorders in Indonesia: a single-center experience
Novie Amelia Chozie, Melati Arum Satiti, Damayanti Rusli Sjarif et al.
Blood Res 2022; 57(2): 129-134  https://doi.org/10.5045/br.2022.2021219 PDF
Original Articles
Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk
Stephanie Wo, Hannah Levavi, John Mascarenhas et al.
Blood Res 2022; 57(2): 135-143  https://doi.org/10.5045/br.2022.2021163 PDF
Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
Seo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee et al.
Blood Res 2022; 57(2): 144-151  https://doi.org/10.5045/br.2022.2021137 PDF
Favorable outcomes with durable chimerism after hematopoietic cell transplantation using busulfan and fludarabine-based reduced-intensity conditioning for pediatric patients with hemophagocytic lymphohistiocytosis
Jin Kyung Suh, Young Kwon Koh, Sung Han Kang et al.
Blood Res 2022; 57(2): 152-157  https://doi.org/10.5045/br.2022.2022047 PDF
Letters to the Editor
Philadelphia-positive (PH+) acute lymphoblastic leukemia (ALL): developing strategies for curing this stubborn disease
Christopher Chin Keong Liam, Yang Liang Boo, Siew Lian Chong et al.
Blood Res 2022; 57(2): 158-161  https://doi.org/10.5045/br.2022.2020305 PDF
A rare case of primary plasma cell leukemia exhibiting the small-cell variant of plasma cells
Jung-Ah Kim, Woo Yong Shin, Jieun Kim et al.
Blood Res 2022; 57(2): 161-164  https://doi.org/10.5045/br.2022.2022059 PDF
Enrichment of TP53 alterations within GCB-like DNA subclassifications of diffuse large B-cell lymphoma after transition from de-novo to relapsed or refractory disease
Shelby Lund, Valentine Ngisa, Kennedee Weber et al.
Blood Res 2022; 57(2): 164-169  https://doi.org/10.5045/br.2022.2022052 PDF
An infant with severe hemophilia A with intracranial hemorrhage mistaken for child abuse: a case report
Ji Won Youn, Ye Jee Shim, Jun Chul Byun et al.
Blood Res 2022; 57(2): 169-171  https://doi.org/10.5045/br.2022.2022073 PDF

Current Issue

30 June 2022 Volume 57.
Number 2 pp. 101~94

SCImago Journal & Country Rank

Today : 298  /
Total : 478,541